TW221049B - - Google Patents

Info

Publication number
TW221049B
TW221049B TW081109989A TW81109989A TW221049B TW 221049 B TW221049 B TW 221049B TW 081109989 A TW081109989 A TW 081109989A TW 81109989 A TW81109989 A TW 81109989A TW 221049 B TW221049 B TW 221049B
Authority
TW
Taiwan
Application number
TW081109989A
Other languages
Chinese (zh)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of TW221049B publication Critical patent/TW221049B/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C381/00Compounds containing carbon and sulfur and having functional groups not covered by groups C07C301/00 - C07C337/00
    • C07C381/10Compounds containing sulfur atoms doubly-bound to nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW081109989A 1991-12-20 1992-12-14 TW221049B (https=)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81225991A 1991-12-20 1991-12-20

Publications (1)

Publication Number Publication Date
TW221049B true TW221049B (https=) 1994-02-11

Family

ID=25209033

Family Applications (1)

Application Number Title Priority Date Filing Date
TW081109989A TW221049B (https=) 1991-12-20 1992-12-14

Country Status (17)

Country Link
EP (1) EP0552553B1 (https=)
JP (1) JP3202373B2 (https=)
AU (1) AU654069B2 (https=)
BR (1) BR9205020A (https=)
CA (1) CA2085297A1 (https=)
CZ (1) CZ365392A3 (https=)
DE (1) DE69221114T2 (https=)
ES (1) ES2104857T3 (https=)
FI (1) FI925693A7 (https=)
HU (1) HUT65746A (https=)
IL (1) IL104088A0 (https=)
MX (1) MX9207264A (https=)
NO (1) NO924848L (https=)
NZ (1) NZ245458A (https=)
TW (1) TW221049B (https=)
YU (1) YU107692A (https=)
ZA (1) ZA929699B (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS65492B1 (sr) * 2017-07-24 2024-05-31 Novartis Ag Jedinjenja i kompozicije za lečenje stanja povezanih sa aktivnošću nlrp
CN111094242B (zh) * 2017-07-24 2024-02-09 诺华股份有限公司 用于治疗与nlrp活性相关的病症的化合物和组合物
US11623922B2 (en) 2017-10-03 2023-04-11 Inflazome Limited Compounds
CN112654350A (zh) * 2018-07-03 2021-04-13 诺华股份有限公司 使用nlrp3拮抗剂治疗对tnf抑制剂有抗性的受试者或针对所述患者选择治疗的方法
EP3880666B1 (en) 2018-11-13 2023-06-28 Novartis AG Compounds and compositions for treating conditions associated with nlrp activity
CN113015730A (zh) 2018-11-13 2021-06-22 诺华股份有限公司 用于治疗与nlrp活性相关的病症的化合物和组合物
US20230059136A1 (en) * 2018-11-16 2023-02-23 Novartis Ag The compounds and compositions for treating conditions associated with nlrp activity
WO2021002887A1 (en) * 2019-07-02 2021-01-07 Novartis Inflammasome Research, Inc. Gut-targeted nlrp3 antagonists and their use in therapy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4666506A (en) 1984-08-08 1987-05-19 E. I. Du Pont De Nemours And Company Herbicidal pyrimidines
IL83215A (en) * 1986-07-23 1991-12-15 Lilly Co Eli Synthesis of bicyclic heteroaromatic sulfonyl chlorides
US5187189A (en) * 1991-01-22 1993-02-16 American Home Products Corporation S-aminoalkyl-s-arylsulfoximines as antiarrhythmic agents
US5140026A (en) * 1991-05-09 1992-08-18 A. H. Robins Company, Incorporated N-aminoalkyl-S-aryl-S-alkyl (or substituted alkyl) sulfoximines as antiarrhythmic agents

Also Published As

Publication number Publication date
CA2085297A1 (en) 1993-06-21
NZ245458A (en) 1995-04-27
NO924848L (no) 1993-06-21
EP0552553B1 (en) 1997-07-23
JPH05345756A (ja) 1993-12-27
EP0552553A1 (en) 1993-07-28
AU654069B2 (en) 1994-10-20
MX9207264A (es) 1993-12-01
BR9205020A (pt) 1993-06-22
NO924848D0 (no) 1992-12-15
HUT65746A (en) 1994-07-28
YU107692A (sh) 1995-12-04
FI925693A7 (fi) 1993-06-21
DE69221114D1 (de) 1997-08-28
JP3202373B2 (ja) 2001-08-27
DE69221114T2 (de) 1997-12-11
AU3018192A (en) 1993-06-24
ES2104857T3 (es) 1997-10-16
HU9203971D0 (en) 1993-04-28
FI925693A0 (fi) 1992-12-15
IL104088A0 (en) 1993-05-13
ZA929699B (en) 1994-06-14
CZ365392A3 (en) 1993-10-13

Similar Documents

Publication Publication Date Title
DE4291016T1 (https=)
DE4292014T1 (https=)
TW221049B (https=)
DK0549782T3 (https=)
DK0538124T3 (https=)
DE4290056T1 (https=)
JPH0496177U (https=)
ECSM91576U (https=)
ECSDI910053S (https=)
JPH0499626U (https=)
ECSDI910048S (https=)
DK132791D0 (https=)
ECSM91555U (https=)
ECSM91528U (https=)
ECSM91558U (https=)
ECSM91536U (https=)
ECSM91540U (https=)
ECSM91550U (https=)
AU8552391A (https=)
EP0527643A3 (https=)
AU7352091A (https=)
AU6943491A (https=)
AU2053992A (https=)
AU7520491A (https=)
CN3009788S (https=)